OTCMKTS:YECO EV Biologics (YECO) Stock Price, News & Analysis → If you have $2,500 bucks… check this out (From DTI) (Ad) Free YECO Stock Alerts $0.62 +0.02 (+3.32%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.60▼$0.6250-Day Range$0.56▼$0.9952-Week Range$0.56▼$1.95Volume3,220 shsAverage Volume46 shsMarket Capitalization$6.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get EV Biologics alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About EV Biologics Stock (OTCMKTS:YECO)EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.Read More YECO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YECO Stock News HeadlinesMarch 22, 2024 | morningstar.comNurExone Biologic Inc NRXBFFebruary 21, 2024 | usatoday.comBest EV stocks in February 2024April 27, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… January 24, 2024 | finance.yahoo.comSoft Tissue Biologics Product Pipeline Report 2023: Reveals Key Development Stages, Industry Trends, Regions, and CompaniesJanuary 24, 2024 | finance.yahoo.comFill Finish Manufacturing Market Forecast Report - A US$ 17.165 Billion Market by 2030, Amplified by Rising Demand for Prefilled SyringesDecember 15, 2023 | uk.investing.comY Biologics Inc (338840)October 17, 2023 | reuters.comChinese EV startup WM Motor files for pre-restructuringOctober 4, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Updates on Funding and SalesApril 27, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… October 2, 2023 | finance.yahoo.comEV Biologics Updates on Funding and SalesAugust 16, 2023 | finance.yahoo.comEV Biologics Completes Production of Cutting-Edge MSC Exosome-Based TherapeuticAugust 7, 2023 | finance.yahoo.comEV Biologics Appoints Senior Investment Banker as Corporate Finance DirectorAugust 3, 2023 | money.usnews.comHow the New EV Tax Credit Will Affect Your Auto LoanAugust 2, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Hires Senior Chief Financial OfficerAugust 2, 2023 | finance.yahoo.comEV Biologics Hires Senior Chief Financial OfficerJuly 30, 2023 | news.yahoo.comToyota is planning a new EV with a 900-mile range and 10-minute charging time: ‘The holy grail of battery vehicles’July 16, 2023 | usatoday.comAre you a gas guzzler? The government might try to persuade you to switch to an EVJune 21, 2023 | usatoday.comHow reliable are public EV charging stations? Report shows many EV drivers have issuesMay 27, 2023 | finance.yahoo.comEV Biologics, Inc. (YECO)May 17, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Signs Exclusive Distribution Agreement for South AmericaMay 15, 2023 | finance.yahoo.comEV Biologics Signs Exclusive Distribution Agreement for South AmericaMay 11, 2023 | benzinga.comBest EV Penny StocksApril 30, 2023 | washingtonpost.comGM to scrap Chevy Bolt, its most popular and least expensive EVMarch 19, 2023 | a.msn.comTesco EV charging network reaches 600 UK stores – and rapid chargers go liveFebruary 21, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Generates Mesenchymal Stem Cell LinesFebruary 21, 2023 | finance.yahoo.comEV Biologics Generates Mesenchymal Stem Cell LinesJanuary 3, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Updates on Excyte Subsidiary FundingSee More Headlines Receive YECO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EV Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConstruction Industry Concrete, gypsum, & plaster products Sub-IndustryN/A Current SymbolOTCMKTS:YECO CUSIPN/A CIK1607741 Webwww.evbiologics.com Phone(518) 638-8192FaxN/AEmployees284Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares10,230,000Free Float6,006,000Market Cap$6.16 million OptionableNot Optionable Beta-0.50 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Daniel S. McKinney (Age 62)Founder, Chairman & CEO Mr. Monte FisherChief Financial OfficerMr. William BossungCorporate Finance Director & Corporate SecretaryKey CompetitorsEnergy FocusNASDAQ:EFOICEA IndustriesNASDAQ:CEADENGlobalNASDAQ:ENGIntelligent Living Application GroupNASDAQ:ILAGWANG & LEE GROUPNASDAQ:WLGSView All Competitors YECO Stock Analysis - Frequently Asked Questions How have YECO shares performed in 2024? EV Biologics' stock was trading at $1.00 at the beginning of 2024. Since then, YECO stock has decreased by 39.8% and is now trading at $0.6021. View the best growth stocks for 2024 here. How do I buy shares of EV Biologics? Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:YECO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EV Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
